New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 30, 2020 - Lupin launched an AB-rated generic version of Novartis’ Tykerb (lapatinib) tablets.
Download PDF
Return to publications
